An Qi, Wang Dongmei, Huang Liang, Chen Xiangyu, Wang Chuan
Scientific Reasearch and Teaching Department, Public Health Clinical Center of Chengdu, Chengdu, Sichuan, China.
National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, China.
Front Pharmacol. 2024 Oct 21;15:1498728. doi: 10.3389/fphar.2024.1498728. eCollection 2024.
Multifunctional nanomaterials are emerging as promising tools for treating both cancer and bacterial infections. However, integrating dual therapeutic capabilities into a single system remains challenging. This study presents multifunctional nanoparticles (ECI-NPs) based on Epigallocatechin gallate (EGCG) oligomers, Curcumin (CUR), and Indocyanine Green (ICG) for combined cancer and bacterial treatment.
ECI-NPs were synthesized via oxidative coupling of EGCG, CUR, and ICG. The nanoparticles were characterized for stability, size, drug loading, and release profiles. Cellular uptake, phototoxicity in melanoma cells, and antibacterial activity against and were also evaluated.
ECI-NPs demonstrated optimal stability, high drug loading, and controlled release. Cellular studies showed increased uptake and greater phototoxicity in melanoma cells compared to free drugs. ECI-NPs also exhibited enhanced anticancer effects and strong antibacterial activity, outperforming the individual components.
The polyphenol-based ECI-NPs offer synergistic therapeutic effects, overcoming the limitations of free drugs in terms of solubility and efficacy. This dual-function platform shows potential for broader biomedical applications, addressing challenges in cancer and bacterial infections. Further research will focus on in vivo studies and clinical translation.
多功能纳米材料正成为治疗癌症和细菌感染的有前景的工具。然而,将双重治疗能力整合到单一系统中仍然具有挑战性。本研究提出了基于表没食子儿没食子酸酯(EGCG)低聚物、姜黄素(CUR)和吲哚菁绿(ICG)的多功能纳米颗粒(ECI-NPs),用于联合癌症和细菌治疗。
通过EGCG、CUR和ICG的氧化偶联合成ECI-NPs。对纳米颗粒的稳定性、尺寸、药物负载和释放曲线进行了表征。还评估了细胞摄取、黑色素瘤细胞中的光毒性以及对[具体细菌1]和[具体细菌2]的抗菌活性。
ECI-NPs表现出最佳的稳定性、高药物负载和可控释放。细胞研究表明,与游离药物相比,黑色素瘤细胞对ECI-NPs的摄取增加且光毒性更大。ECI-NPs还表现出增强的抗癌作用和强大的抗菌活性,优于单个成分。
基于多酚的ECI-NPs具有协同治疗作用,克服了游离药物在溶解度和疗效方面的局限性。这个双功能平台在更广泛的生物医学应用中显示出潜力,解决了癌症和细菌感染方面的挑战。进一步的研究将集中在体内研究和临床转化上。